HRID 352055As product
Completing data — refresh the page later to see the latest
366017-09-6FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1ZTFBIUXIQYRUNT-MDWZMJQESA-NMubritinib has been used in trials studying the treatment of Lung Neoplasm, Renal Neoplasm, Breast Neoplasm, Ovarian Neoplasm, and Pancreatic Neoplasm.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesTreatment of cancer.
UsesMubritinib is used in selective targeting of CTNNB1-, KRAS-or MYC-driven human cancer cell growth by combinations of existing drugs
366017-09-6DTXSID501026014CHEMBL1614707CHEBI:233310